Next Article in Journal
Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics
Next Article in Special Issue
Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein
Previous Article in Journal
Chikungunya Virus: Priority Pathogen or Passing Trend?
Previous Article in Special Issue
Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study
 
 
Article

Article Versions Notes

Vaccines 2023, 11(3), 570; https://doi.org/10.3390/vaccines11030570
Action Date Notes Link
article xml file uploaded 1 March 2023 12:00 CET Original file -
article xml uploaded. 1 March 2023 12:00 CET Update https://www.mdpi.com/2076-393X/11/3/570/xml
article pdf uploaded. 1 March 2023 12:00 CET Version of Record https://www.mdpi.com/2076-393X/11/3/570/pdf
article supplementary file uploaded. 1 March 2023 12:00 CET - https://www.mdpi.com/2076-393X/11/3/570#supplementary
article html file updated 1 March 2023 12:01 CET Original file https://www.mdpi.com/2076-393X/11/3/570/html
Back to TopTop